Public health lawfully outlaws the patent rights: a story of March-in rights!
My previous posts on the open-source innovation read with Doha style compulsory licensing and revocation in the public interest were exhaustive on the access to […]
patents
From the bolar provision to the issuance of the compulsory license and revocation in the public interest – Remdesivir drug of Gilead is a complete course on patent law
The time since the experts have suggested “Remdesivir” as a possible drug to fight against COVID-19, global debate over obtaining this drug is started. The […]
What is common between the Apple/Samsung case and cases initiated by patent trolls? Both can be seen in the light of the excessive IPRs protection measures performed in the US by the International Trade Commission (ITC).
What is the ITC? Having great political influence, the United States has been repeatedly accused of harming developing countries in its attempts to push for […]
Unrecognizing the recognizable: Addressing the rapper’s dilemma in light of the German case law
*This article is going to be interesting because of three reasons. One, it talks about Sampling in the music industry; two, how European Union Directives […]
Unified Patent Court: Was the German Constitutional Court’s decision the final blow to a big dream?
Despite the fact that the COVID-19 crisis is in the epicentre of the media coverage and social media, on the 20th of March, the long-awaited […]
Open Source Innovation in the pharmaceuticals: Is that all for public health?
Dear Readers, I hope you are reading this post in your good health and essentially operable outdoor conditions. In this unfortunate time, when the world […]